{
  "meta": {
    "title": "71_Rh_Isoimmunization",
    "url": "https://brainandscalpel.vercel.app/71-rh-isoimmunization-f4ff7cb1.html",
    "scrapedAt": "2025-11-30T17:51:45.074Z"
  },
  "questions": [
    {
      "text": "All of the following statements about Rh isoimmunisation are true except:",
      "choices": [
        {
          "id": 0,
          "text": "Occurs when Rh-ve mother encounters Rh+ve fetal blood"
        },
        {
          "id": 1,
          "text": "Mother first produces IgM, then IgG antibodies against the Rh antigen"
        },
        {
          "id": 2,
          "text": "Maternal-fetal ABO incompatibility can increase the risk"
        },
        {
          "id": 3,
          "text": "Methergine use during labor can increase the risk"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) Maternal-fetal ABO <span class=\"customMeta\" data-dictid=\"722db2c56816927771903e6469e2dc\">incompatibility</span> can increase the risk</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li><strong>Maternal-fetal ABO incompatibility</strong> have a <strong>protective effect </strong>rather than increasing the risk of Rh isoimmunisation.</li>\n\t<li>The mother's existing antibodies eliminate <span class=\"customMeta\" data-dictid=\"10dcdd93561692777190d73418c5a7\">incompatible</span> <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> cells before they can trigger a significant <span class=\"customMeta\" data-dictid=\"dc6add5cf91692777189b30a6bae38\">immune response</span> to the Rh antigen.</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Rh Isoimmunisation:</strong></p>\n\n<ul>\n\t<li>Occurs when an <strong>Rh-negative mother </strong>is exposed to <strong>Rh-positive <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> blood</strong>, most commonly during delivery, miscarriage, <span class=\"customMeta\" data-dictid=\"0decefe0901692777186f7f3f89b2a\">ectopic</span> pregnancy, or procedures like amniocentesis. This exposure sensitizes the mother’s immune system to the D antigen. <strong>(Option A) </strong></li>\n\t<li>The <strong>mother's immune system</strong>, once <span class=\"customMeta\" data-dictid=\"e1c24f762816927771989a2101cb3c\">sensitized</span> to the Rh antigen, initially <strong>produces IgM antibodies</strong>, which cannot cross the placenta. These are usually <strong>followed by</strong> the production of <strong>IgG</strong> <strong>antibodies</strong>, which can cross the <span class=\"customMeta\" data-dictid=\"5276da31d11692777195f0e82f5e1d\">placenta</span> and lead to <span class=\"customMeta\" data-dictid=\"c2b082746716927771888f0933941d\">hemolysis</span> of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> red blood cells in the subsequent pregnancies. <strong>(Option B) </strong></li>\n</ul>\n\n<p style=\"text-align:center\"><img alt=\"Rh incompatibility\" data-author=\"\" data-hash=\"229\" data-license=\"\" data-source=\"\" data-tags=\"November2024\" height=\"473\" src=\"https://image.prepladder.com/notes/em2JxRFjKAHqx9ChQDKq1732422061.jpg\" width=\"518\" /></p>\n\n<ul>\n\t<li>The <span class=\"customMeta\" data-dictid=\"a87d6eeedb16927771967434e19075\">prophylactic</span> use of<strong> <span class=\"customMeta\" data-dictid=\"fdcbf0e9f71692777192931a9e29d6\">methergine</span> </strong>(ergometrine) during labor, can potentially increase fetomaternal <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> that can <strong>elevate the risk of Rh isoimmunisation</strong> by allowing more <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> red blood cells to enter the mother's circulation. <strong>(Option D) </strong></li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/notes/em2JxRFjKAHqx9ChQDKq1732422061.jpg"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/WEzAHIO9QyaZtV3wGFsC1751010393.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/L0EDejPk2LTJNaItTR9C1751010519.mp3"
    },
    {
      "text": "A term newborn, delivered via LSCS to a 30-year-old G2P1 woman with O-negative blood type and inadequate prenatal care, presents with generalized edema, ascites, pallor, severe respiratory distress, and hepatosplenomegaly. The infant is critically ill and admitted to the NICU. What is the likely diagnosis?",
      "choices": [
        {
          "id": 0,
          "text": "Congenital Anemia of Newborn"
        },
        {
          "id": 1,
          "text": "Icterus Gravis Neonatorum"
        },
        {
          "id": 2,
          "text": "Hydrops Fetalis"
        },
        {
          "id": 3,
          "text": "Prematurity"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">Hydrops</span> Fetalis</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>The baby looks pale and edematous with an enlarged <span class=\"customMeta\" data-dictid=\"ac388c59831692777180f5a8e12913\">abdomen</span> due to ascites, this is characteristic of <strong>Hydrops fetalis</strong>, a <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of<strong> </strong><strong>hemolytic disease of the <span class=\"customMeta\" data-dictid=\"421fecf0e21692777202704942ac48\">fetus</span> and <span class=\"customMeta\" data-dictid=\"04df903fe8169277719383126b1b02\">newborn</span> (HDFN).</strong> </p>\n\n<ul>\n\t<li><strong>Hydrops</strong> is diagnosed by identifying two or more <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> effusions – <strong>pleural, pericardial, or ascites</strong> – <strong>or one <span class=\"customMeta\" data-dictid=\"73909075e71692777187f08d3c9b7e\">effusion</span> plus anasarca. </strong></li>\n\t<li><strong>Pathophysiology of <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">hydrops</span> fetalis:</strong></li>\n</ul>\n\n<p style=\"text-align:center\"><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"398\" src=\"https://image.prepladder.com/content/GSBBx5IHjXFdpgOGKuQv1726293096.jpg\" width=\"347\" /></p>\n\n<p><strong>Congenital <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">Anemia</span> of the <span class=\"customMeta\" data-dictid=\"04df903fe8169277719383126b1b02\">Newborn</span> (Option A)</strong> is the <strong>mildest <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of HDFN</strong>, characterized by slow destruction of RBCs in the first few weeks of life, leading to anemia, enlarged liver, and spleen, but typically without noticeable jaundice. Unlike <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">Hydrops</span> fetalis, it does not present with <span class=\"customMeta\" data-dictid=\"18b452e75916927771864c9ad533e1\">edema</span> and <span class=\"customMeta\" data-dictid=\"a1146fb9d8169277718250cf1224a8\">ascites</span> in the baby.</p>\n\n<p> </p>\n\n<p><strong>Icterus Gravis Neonatorum (Option B) </strong>is the <strong>moderate <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of HDFN</strong> presents as jaundice, developing within 24 hours of birth due to a build-up of unconjugated bilirubin, a <span class=\"customMeta\" data-dictid=\"1635abe5e5169277718365a15769c5\">by-product</span> of <span class=\"customMeta\" data-dictid=\"8790b4667016927771979066e8958c\">RBC</span> breakdown. The infant's liver can't process the <span class=\"customMeta\" data-dictid=\"7a1ae24f701692777187a7f60bbd9f\">excess</span> bilirubin, which can reach toxic levels and potentially lead to kernicterus, a type of brain damage. The baby in this scenario has anasarca, indicating <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">Hydrops</span> fetalis.</p>\n\n<p> </p>\n\n<p><strong>Prematurity (Option C): </strong>The given condition does not indicate prematurity.</p>",
      "question_images": [
        "https://image.prepladder.com/content/mAeiyEiDTY1sGnq2LbOj1726293012.png"
      ],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/GSBBx5IHjXFdpgOGKuQv1726293096.jpg"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/NqSYdJ6KbBkflpSTCF9P1746178085.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/oJQ6xnqOcVjUzBhyF5qk1746178194.mp3"
    },
    {
      "text": "A 25 year old Rh-negative woman presents to her obstetrician a day after she experienced a spontaneous miscarriage at 10 weeks gestation. She has no history of RhIG administration. What is the appropriate management to prevent Anti-D alloimmunization in this patient?",
      "choices": [
        {
          "id": 0,
          "text": "Administer 300 μg of RhIG intramuscularly"
        },
        {
          "id": 1,
          "text": "Administer 50 μg of RhIG intramuscularly"
        },
        {
          "id": 2,
          "text": "No RhIG administration needed at this stage"
        },
        {
          "id": 3,
          "text": "Check for fetomaternal hemorrhage"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) Administer 50 μg of RhIG intramuscularly</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Pregnancy</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Rh Anti-D dosing</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>First Trimester</strong> (Miscarriage, Abdominal trauma, Ectopic)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>50 μg</strong>, administered within 72 hours. <strong>(Option B)</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>28 weeks</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>300 μg of RhIG</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>After delivery </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>300 μg of RhIG</strong> (ideally within 72 hours but can be given up to 4 weeks) <strong>(Option A)</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<ul>\n\t<li>The standard <span class=\"customMeta\" data-dictid=\"8a99f9c37f16927771902daa814697\">intramuscular</span> dose of anti-D immune globulin, 300 μg or 1500 IU, will protect the average-sized mother from a <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"4642acfc0c16927771880b34fa5174\">hemorrhage</span> of up to 30 mL of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"60d609888b169277720258496ef45a\">whole blood</span> or 15 mL of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> red cells.</li>\n\t<li><strong>RhIG administration (Option C) </strong>is recommended after pregnancy-related events like <span class=\"customMeta\" data-dictid=\"423516578d1692777192412d27cc61\">miscarriage</span> to prevent Anti-D alloimmunization, regardless of <span class=\"customMeta\" data-dictid=\"2727bb69eb1692777188a09a87f2b8\">gestational age</span> .</li>\n\t<li><strong>Checking for fetomaternal hemorrhage (Option D)</strong> is not needed for sensitizing events before 20 weeks .</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/WDQQ2Tbzf5ifAFt1RGE61751010666.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/Jc15ryJKhgKfOCS7o5561751010786.mp3"
    },
    {
      "text": "A pregnant woman at term with a weight of 60 kg with an approximate blood volume of 5000ml is found to have a 2% contamination of fetal-maternal hemorrhage (FMH). Calculate the dose of Anti-D required for Rh immunoprophylaxis.",
      "choices": [
        {
          "id": 0,
          "text": "300 μg"
        },
        {
          "id": 1,
          "text": "600 μg"
        },
        {
          "id": 2,
          "text": "1000 μg"
        },
        {
          "id": 3,
          "text": "1300 μg"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) 1000 μg</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p><strong>Anti-D is given as 10 µg for every 1 mL of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> whole blood, or for every 0.5 ml of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> RBC:</strong></p>\n\n<ul>\n\t<li>Maternal blood volume= 5000 ml = 5 L</li>\n\t<li>Fetal-Maternal Hemorrhage = 2%</li>\n\t<li>FMH volume = 2% of 5000 ml = 0.02 × 5000 ml = 100 ml</li>\n\t<li>Therefore, Anti-D dose = 10 μg/ml × 100 ml =<strong> 1000 μg</strong>.</li>\n</ul>\n\n<p> </p>\n\n<p> </p>\n\n<p><strong>Kleihauer Betke Test (Acid <span class=\"customMeta\" data-dictid=\"7c0d452a441692777187ce1b15aae3\">Elution</span> Technique):</strong></p>\n\n<ul>\n\t<li>Primarily used to detect and quantify the presence of <strong>fetal red blood cells (RBCs)</strong> in the <span class=\"customMeta\" data-dictid=\"a191a950d7169277719148e72a75e2\">maternal</span> circulation.</li>\n\t<li>This is crucial for <strong>determining the appropriate dose of anti-D immune globulin</strong> in D-negative pregnant women to prevent Rh immunization.</li>\n\t<li><strong>Principle:</strong> <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">Fetal</span> RBCs contain <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> F, which is more resistant to acid <span class=\"customMeta\" data-dictid=\"7c0d452a441692777187ce1b15aae3\">elution</span> compared to adult <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> (hemoglobin A), when immersed in a <span class=\"customMeta\" data-dictid=\"3569209ba41692777184f88db9316d\">citrate</span> buffer, the HbF remained intact while the HbA leaked out.</li>\n\t<li>In the KB test, <span class=\"customMeta\" data-dictid=\"a191a950d7169277719148e72a75e2\">maternal</span> blood is exposed to acid, which causes adult <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> to wash out (ghosts), leaving behind the more resistant <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> hemoglobin.</li>\n</ul>\n\n<p style=\"text-align:center\"><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"330\" src=\"https://image.prepladder.com/content/FbP9uvafvZzdRlaSwkZ41726293270.png\" width=\"206\" /></p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/FbP9uvafvZzdRlaSwkZ41726293270.png"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/7fi1As3YVNJu6KFLTJnn1751010950.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/cCz5RO7ZGNX0Sbr39j8e1751011037.mp3"
    },
    {
      "text": "A 30-year-old G3P1A1 woman, Rh-negative, at 28 weeks of gestation, presents for a routine antenatal visit. Her first child is Rh-positive, and she had a spontaneous abortion at 10 weeks during her second pregnancy. Her initial ICT was negative, but at 28 weeks, a repeat ICT is positive with a titer of 1:32. What is the next best step in her antenatal management?",
      "choices": [
        {
          "id": 0,
          "text": "Administer anti-D immunoglobulin immediately"
        },
        {
          "id": 1,
          "text": "Monitor fetal MCA Doppler"
        },
        {
          "id": 2,
          "text": "Routine follow-up in 4 weeks"
        },
        {
          "id": 3,
          "text": "Early delivery at 34 weeks"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) Monitor <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> MCA Doppler </strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li><strong>MCA (Middle Cerebral Artery) Doppler ultrasound</strong> is a non-invasive method to assess <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> anemia, which can occur due to Rh isoimmunization.</li>\n\t<li><strong>MCA PSV >1.5 MoM</strong> for the corresponding gestational age, predicts a moderate to severe degree of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> anemia.</li>\n\t<li>Currently, <strong>MCA PSV</strong> is the <strong>mainstay of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> surveillance</strong> in a case with red cell alloimmunization.</li>\n\t<li>This value (between 24 and 35 weeks of gestation), is an indication of <strong>cordocentesis</strong> and <strong>intrauterine <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> transfusion</strong></li>\n</ul>\n\n<p><strong>Algorithm of Antenatal Management of Rh Isoimmunisation:</strong></p>\n\n<p style=\"text-align:center\"><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"574\" src=\"https://image.prepladder.com/content/VDGkyhRmfdfVJjLbXHGG1726293427.jpg\" width=\"358\" /></p>\n\n<p><strong>Administer anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> immediately (Option A): </strong>Anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> is administered to Rh-negative mothers who are not <span class=\"customMeta\" data-dictid=\"e1c24f762816927771989a2101cb3c\">sensitized</span> (negative ICT) to prevent Rh isoimmunization. In this case, the patient already has a positive ICT with a significant <span class=\"customMeta\" data-dictid=\"07e6f3a1921692777200051f692a60\">titer</span> (critical <span class=\"customMeta\" data-dictid=\"07e6f3a1921692777200051f692a60\">titer</span> values > 1:16), indicating sensitization, so administering anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> will not be effective.</p>\n\n<p><strong>Routine follow-up in 4 weeks (Option C)</strong>: Given the ICT with a single positive titer, routine follow-up without specific assessment for <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> is not appropriate. This patient requires closer monitoring due to the risk of <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> disease of the <span class=\"customMeta\" data-dictid=\"421fecf0e21692777202704942ac48\">fetus</span> and <span class=\"customMeta\" data-dictid=\"04df903fe8169277719383126b1b02\">newborn</span> (HDFN)</p>\n\n<p><strong>Early delivery at 34 weeks (Option D)</strong>: Early delivery might be considered if severe <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> or <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">hydrops</span> fetalis is detected and <span class=\"customMeta\" data-dictid=\"1d5d2712dc169277719050154d38a1\">intrauterine</span> <span class=\"customMeta\" data-dictid=\"cbb73554631692777200444a9ea263\">transfusion</span> is not feasible or has failed. However, this decision would be based on MCA-PSV Doppler findings.  </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/VDGkyhRmfdfVJjLbXHGG1726293427.jpg"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/p4AKabwfukq1HUfNl2ah1751011170.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/GjAxpCYdBxLhTfiUfxeE1751011298.mp3"
    },
    {
      "text": "A 25-year-old Rh-negative woman, G2P1, at 28 weeks of gestation, presents for a routine antenatal visit. Her first child is Rh-positive, and she received anti-D postpartum. She reports falling on her stomach but is not experiencing any abdominal pain or bleeding. Her ICT is negative. What is the most appropriate management step regarding Rh isoimmunization?",
      "choices": [
        {
          "id": 0,
          "text": "Administer a standard prophylactic dose of anti-D immunoglobulin immediately"
        },
        {
          "id": 1,
          "text": "Schedule a USG to check for placental abruption"
        },
        {
          "id": 2,
          "text": "Repeat ICT in 2 weeks to monitor for sensitization"
        },
        {
          "id": 3,
          "text": "No intervention is needed as the patient is asymptomatic"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Answer: A) Administer a standard <span class=\"customMeta\" data-dictid=\"a87d6eeedb16927771967434e19075\">prophylactic</span> dose of anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> immediately</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li>Even <strong>blunt <span class=\"customMeta\" data-dictid=\"1665a40f1016927771801899eaed5d\">abdominal</span> trauma</strong> can cause a trivial <span class=\"customMeta\" data-dictid=\"32583099e91692777200c34d388c09\">transplacental</span> hemorrhage, which can lead to <strong>Rh sensitization.</strong></li>\n\t<li>A Standard <strong>Prophylactic anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> </strong>should be given to all Rh-negative pregnant women at 28 weeks and within 72 hours of delivery of a Rh+ve baby.</li>\n</ul>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:NaN\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Standard 300 µg of anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> IM dose will protect a mother from <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"4642acfc0c16927771880b34fa5174\">hemorrhage</span> of up to 30 mL of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"60d609888b169277720258496ef45a\">whole blood</span> or 15 mL of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> RBCs.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:NaN\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Causes of Feto-Maternal Haemorrhage and Indications of Anti-D Immunoglobulin</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Abdominal trauma</li>\n\t\t\t\t<li>Miscarriage</li>\n\t\t\t\t<li>Medical <span class=\"customMeta\" data-dictid=\"a35c217ec416927772009a7f3b20f4\">termination</span> of pregnancy</li>\n\t\t\t\t<li>Ectopic pregnancy</li>\n\t\t\t\t<li>Chorion <span class=\"customMeta\" data-dictid=\"b0bb7d5b6716927772028625a93e1e\">villus</span> biopsy</li>\n\t\t\t\t<li>Cordocentesis</li>\n\t\t\t\t<li>Genetic amniocentesis</li>\n\t\t\t\t<li>Delivery of an Rh-positive infant to Rh-negative mother: postpartum</li>\n\t\t\t\t<li>ECV (External Cephalic Version)</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><strong>Schedule a USG to check for <span class=\"customMeta\" data-dictid=\"797686400a16927771956b27d401ff\">placental</span> abruption (Option A): </strong>While a USG may be useful to assess the <span class=\"customMeta\" data-dictid=\"5276da31d11692777195f0e82f5e1d\">placenta</span> and <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> well-being after trauma, in the absence of symptoms such as <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> or pain, it is not the immediate priority in managing Rh isoimmunization. The focus should be on preventing <span class=\"customMeta\" data-dictid=\"4fe92aaac71692777198234aaa055a\">sensitization</span> with anti-D immunoglobulin.</p>\n\n<p><strong>Repeat ICT in 2 weeks to monitor for <span class=\"customMeta\" data-dictid=\"4fe92aaac71692777198234aaa055a\">sensitization</span> (Option C):</strong> Repeating the ICT alone is not sufficient as a preventative measure. By the time <span class=\"customMeta\" data-dictid=\"4fe92aaac71692777198234aaa055a\">sensitization</span> is detected on an ICT, it is too late for prophylaxis. <span class=\"customMeta\" data-dictid=\"a87d6eeedb16927771967434e19075\">Prophylactic</span> anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> should be administered immediately</p>\n\n<p><strong>No intervention is needed as the patient is <span class=\"customMeta\" data-dictid=\"d1a9a79f701692777182066af09044\">asymptomatic</span> (Option D):</strong> Even minor trauma can cause fetomaternal hemorrhage, and Rh-negative women should receive <span class=\"customMeta\" data-dictid=\"a87d6eeedb16927771967434e19075\">prophylactic</span> anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> to prevent sensitization.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/4XBj9OdAM7yBhEuwAJ0V1751011434.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/BmV2iDeTmaUEksDxknZA1751011568.mp3"
    },
    {
      "text": "In pregnancies complicated by Rh isoimmunization, which diagnostic procedure involves analyzing the bilirubin levels in amniotic fluid to assess the severity of fetal hemolysis and anemia indirectly?",
      "choices": [
        {
          "id": 0,
          "text": "Doppler ultrasound of MCA-PSV"
        },
        {
          "id": 1,
          "text": "Serial USG monitoring"
        },
        {
          "id": 2,
          "text": "Fetal blood sampling (FBS) via cordocentesis"
        },
        {
          "id": 3,
          "text": "Amniocentesis with ΔOD450 analysis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Answer: D) Amniocentesis with ΔOD450 analysis</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li><strong>Amniocentesis</strong> with <span class=\"customMeta\" data-dictid=\"ccea7fb8c61692777198ee9aeb76dd\">spectral</span> analysis involves obtaining <span class=\"customMeta\" data-dictid=\"2c0fb943ce16927771815ddeb9824d\">amniotic</span> fluid and analyzing it for <strong>bilirubin concentration</strong> using <strong>spectrophotometric analysis (ΔOD450).</strong></li>\n\t<li>This method indirectly <strong>assesses the severity of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> hemolysis</strong> by measuring the presence of bilirubin, which correlates with <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"248111ded81692777197946454db52\">red blood cell</span> breakdown<strong>.</strong></li>\n\t<li>ΔOD450 values are interpreted using<strong> Modified Liley's (Queenan) chart</strong>, depending upon the rise of <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> titer<strong> </strong><strong>(>1: 8)</strong>, to guide management decisions regarding the timing of delivery or the need for <span class=\"customMeta\" data-dictid=\"1d5d2712dc169277719050154d38a1\">intrauterine</span> <span class=\"customMeta\" data-dictid=\"cbb73554631692777200444a9ea263\">transfusion</span> in Rh-sensitized pregnancies.</li>\n\t<li>Usually done<strong> </strong><strong>after 20 weeks</strong> of pregnancy and divided into zones:</li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:612px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align:center\"><strong>Zone</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align:center\"><strong>Clinical Presentation</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align:center\"><strong>Management</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align:center\"><strong>Zone 1 (Low zone)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>The <span class=\"customMeta\" data-dictid=\"421fecf0e21692777202704942ac48\">fetus</span> is unlikely to be affected</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Delivery at term is suggested</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align:center\"><strong>Zone 2 (Mid-zone)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Fetal anemia</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Preterm delivery after 34 weeks or IUT may be needed</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align:center\"><strong>Zone 3 (High zone)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Severe <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> (Hb < 8 g/dL)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Immediate IUT (Intrauterine Transfusion) needed</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p style=\"text-align:center\"><img alt=\"Modified Liley's (Queenan) chart\" data-author=\"\" data-hash=\"232\" data-license=\"\" data-source=\"\" data-tags=\"November2024\" src=\"https://image.prepladder.com/notes/45K2UcC9tGjGUws1ws5H1732471765.jpg\" /></p>\n\n<p> </p>\n\n<p><strong>Doppler <span class=\"customMeta\" data-dictid=\"df077f2c3d16927772019f8223e58f\">ultrasound</span> of MCA-PSV (Option A)</strong> is a non-invasive method with greater sensitivity and accuracy used to assess <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> by measuring <span class=\"customMeta\" data-dictid=\"82cc227a1c169277718387905b50c6\">blood flow</span> velocities in the <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> brain. It focuses on <span class=\"customMeta\" data-dictid=\"82cc227a1c169277718387905b50c6\">blood flow</span> dynamics(Low blood <span class=\"customMeta\" data-dictid=\"2313fc54841692777202a008c72950\">viscosity</span> & increased blood velocity) rather than direct measurement of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"2d60c5a677169277718325a811dcf1\">bilirubin</span> levels.</p>\n\n<p><strong>Serial USG monitoring (Option B): </strong>Although it is crucial for general <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> surveillance, eg. for detecting <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> hydrops, anemia, <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> anomalies, and monitoring growth restriction it does not help in assessing <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"c2b082746716927771888f0933941d\">hemolysis</span> or <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> caused by Rh isoimmunization.</p>\n\n<p><strong>Fetal blood <span class=\"customMeta\" data-dictid=\"521de62abe16927771989a90d0e9e8\">sampling</span> (FBS) via <span class=\"customMeta\" data-dictid=\"55e95ef9fe16927771856fe5e5775f\">cordocentesis</span> (Option C)</strong> involves direct <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> blood analysis from the <span class=\"customMeta\" data-dictid=\"9cc3973459169277720194a0847477\">umbilical</span> cord. It provides detailed information, such as <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> hematocrit, <span class=\"customMeta\" data-dictid=\"249592767b16927771976df58de24d\">reticulocyte</span> count, and <span class=\"customMeta\" data-dictid=\"a3c99b36b6169277718332b20cc393\">blood group</span> compatibility, and is used when other methods indicate severe <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> anemia, typically if MCA PSV is >1.5 MoM.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/notes/45K2UcC9tGjGUws1ws5H1732471765.jpg"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/DPGGtNfYvNVVMbbZwGae1751011915.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/Q1VI29BuHv1KRkY695Yr1751012047.mp3"
    },
    {
      "text": "A 28-year-old pregnant woman at 30 weeks gestation, with a history of Rh isoimmunization and ICT titres above the critical level, presents with signs of moderate hydrops fetalis on ultrasound. MCA-PSV is greater than 1.5 MoM, and cordocentesis reveals that the fetal hematocrit is less than 30%, what is the most appropriate management strategy?",
      "choices": [
        {
          "id": 0,
          "text": "Monitor and terminate the pregnancy at 38 weeks"
        },
        {
          "id": 1,
          "text": "Administer steroids and plan termination at 34 weeks."
        },
        {
          "id": 2,
          "text": "Immediate intrauterine transfusion, then monitor closely."
        },
        {
          "id": 3,
          "text": "Confirm lung maturity, terminate at 34 weeks."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) Immediate <span class=\"customMeta\" data-dictid=\"1d5d2712dc169277719050154d38a1\">intrauterine</span> transfusion, then monitor closely.</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>In cases of <strong>severe <span class=\"customMeta\" data-dictid=\"c2b082746716927771888f0933941d\">hemolysis</span> with <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> compromise </strong>like <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">hydrops</span> fetalis, <strong>immediate <span class=\"customMeta\" data-dictid=\"1d5d2712dc169277719050154d38a1\">intrauterine</span> transfusion</strong> corrects severe anemia. <strong>Close monitoring </strong>to assess response; <span class=\"customMeta\" data-dictid=\"a35c217ec416927772009a7f3b20f4\">termination</span> may be considered if conditions persist despite treatment.</p>\n\n<p><strong>Algorithm of Antenatal Management of Rh Isoimmunisation:</strong></p>\n\n<p><img alt=\"Algorithm of antenatal management of Rh Isoimmunisation\" data-author=\"\" data-hash=\"233\" data-license=\"\" data-source=\"\" data-tags=\"November2024\" src=\"https://image.prepladder.com/notes/mhUx33txWsNCw0PO1iUG1732472463.jpg\" /></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:562px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align: center;\"><strong>Condition</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align: center;\"><strong>Action</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align: center;\"><strong>Mild Affection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Continue pregnancy up to <strong>38 weeks (Option A)</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td rowspan=\"3\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p style=\"text-align: center;\"><strong>Severe Affection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Terminate pregnancy <strong>around 34 weeks</strong> after steroids<strong> (Option B)</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Confirm <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> lung <span class=\"customMeta\" data-dictid=\"76948f718016927771924774ade7e9\">maturation</span> </strong>with L:S ratio (<strong><34 weeks</strong>) <strong>(Option D)</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Intrauterine <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> transfusion</strong> if severe <strong>before 34 weeks (Option C)</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/notes/mhUx33txWsNCw0PO1iUG1732472463.jpg"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/0NWyYDPngR7mBLWGW4W81751012163.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/CW9RkSAU4FtcH6CmPVPK1751012244.mp3"
    },
    {
      "text": "A 2-day-old newborn born to an Rh-negative mother presents with severe jaundice and hemolytic anemia. The mother had anti-D antibodies during pregnancy, and the baby has Hemolytic Disease of the Newborn (HDN). The neonatologist decides to perform an exchange transfusion. Which of the following is NOT a favorable characteristic for selecting blood for the transfusion?",
      "choices": [
        {
          "id": 0,
          "text": "Blood cross-matched with the mother’s serum"
        },
        {
          "id": 1,
          "text": "Freshly collected blood (<7 days old)"
        },
        {
          "id": 2,
          "text": "Blood volume of 80 mL/kg body weight of the baby"
        },
        {
          "id": 3,
          "text": "Group 'O' blood if the same ABO grouping as the baby is unavailable"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) Blood volume of 80 mL/kg body weight of the baby</strong><br />\n </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>The correct amount of blood for <span class=\"customMeta\" data-dictid=\"6a80cf399d16927771875bd0f76dd9\">exchange transfusion</span> is about <strong>160 mL/kg body weight of the baby.</strong> Using only <strong>80 mL/kg would be insufficient</strong> to effectively treat severe <span class=\"customMeta\" data-dictid=\"029f7520711692777190fd7d70c220\">jaundice</span> and <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> anemia.</p>\n\n<p> </p>\n\n<p><strong>Characteristics of Blood for Transfusion:</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:658px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Parameters</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Characteristics</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Rationale</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Blood Type (Option D)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Rh-negative <span class=\"customMeta\" data-dictid=\"60d609888b169277720258496ef45a\">whole blood</span> with the same blood <strong>ABO grouping</strong> as that of the baby, <strong>otherwise group ‘O’.</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>To prevent any further <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> reactions.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Cross-Matching (Option A)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Should be done with the <strong>mother’s serum</strong> or with the infant’s serum</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>To ensure <span class=\"customMeta\" data-dictid=\"9f961c54641692777184ddaf41886b\">compatibility</span> and prevent <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> reactions.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Quality (Option B)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>The <strong>blood </strong>should be collected relatively <strong>fresh (<7 days old)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Ensures better <span class=\"customMeta\" data-dictid=\"a8dece102f16927772026b199f06af\">viability</span> and functionality of the red blood cells.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Amount (Option C)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>About <strong>160 mL/kg body weight of the baby.</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>To adequately treat the condition</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/KoktjH62783ygmz5RVQA1751012377.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/SyT0w76vCdD6KySPNy4D1751012499.mp3"
    },
    {
      "text": "A G2P1L1 woman is seen at 28 weeks. Her blood group is B negative & her husband's blood group is B positive. Her ICT is positive with a titre of 1:8. What is the next step in management?",
      "choices": [
        {
          "id": 0,
          "text": "Administer Anti-D immunoglobulin (RhIg)"
        },
        {
          "id": 1,
          "text": "Monitor ICT titres"
        },
        {
          "id": 2,
          "text": "Perform MCA doppler"
        },
        {
          "id": 3,
          "text": "Perform cordocentesis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) Monitor ICT titres </strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li><strong>ICT is positive </strong>with a <strong>titre of 1:8</strong>, which indicates the presence of <strong>antibodies in the mother's blood against Rh-positive blood cells.</strong></li>\n\t<li>Titre level of 1:8 is relatively low, i.e., <strong>less than the critical <span class=\"customMeta\" data-dictid=\"6c8421504e1692777200e552c3b421\">titre</span> (<1:16)</strong>, and does not immediately indicate severe <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> disease of the <span class=\"customMeta\" data-dictid=\"421fecf0e21692777202704942ac48\">fetus</span> or <span class=\"customMeta\" data-dictid=\"04df903fe8169277719383126b1b02\">newborn</span> (HDFN). Once the critical <span class=\"customMeta\" data-dictid=\"07e6f3a1921692777200051f692a60\">titer</span> of 1 is to 16 is crossed, then we perform MCA Doppler. Once the MCA Doppler is abnormal, then we perform cordocentesis.</li>\n</ul>\n\n<p><strong>Administer Anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> (RhIg) (Option A): </strong>Not effective since the mother is already sensitized.</p>\n\n<p><strong>Perform MCA Doppler (Option C): </strong>Not needed at this low <span class=\"customMeta\" data-dictid=\"6c8421504e1692777200e552c3b421\">titre</span> level; typically done if there’s a higher risk of <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> anemia.</p>\n\n<p><strong>Perform <span class=\"customMeta\" data-dictid=\"55e95ef9fe16927771856fe5e5775f\">Cordocentesis</span> (Option D): </strong>An <span class=\"customMeta\" data-dictid=\"1c5272ad3d1692777190e71409d07a\">invasive</span> procedure reserved for cases with more severe indications, not necessary with a <span class=\"customMeta\" data-dictid=\"6c8421504e1692777200e552c3b421\">titre</span> of 1:8.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/Q0n55twrH3qE2r6DGEZp1751012593.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/Vbry7ue1bd6LYMRDPUlh1751012688.mp3"
    },
    {
      "text": "A 28-year-old Rh-negative woman at 28 weeks gestation, who previously received anti-D immunoglobulin after the birth of an Rh-positive baby, seeks prenatal care. What is the recommended management for anti-D immunoglobulin administration in her current pregnancy?",
      "choices": [
        {
          "id": 0,
          "text": "Administer IM Rh immunoglobulin at 28 weeks gestation."
        },
        {
          "id": 1,
          "text": "Wait until after the delivery to administer Anti-D Immunoglobulin."
        },
        {
          "id": 2,
          "text": "Administer Anti-D Immunoglobulin only if there is evidence of maternal trauma or bleeding."
        },
        {
          "id": 3,
          "text": "No further administration of Anti-D Immunoglobulin is needed during current pregnancy."
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Answer: A) Administer IM Rh <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> at 28 weeks gestation.</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li>The <strong>standard practice</strong> is to administer a dose of<strong> anti-D immunoglobulin</strong> around <strong>28 weeks of gestation.</strong></li>\n\t<li>This timing ensures that any<strong> small amounts of Rh-positive blood</strong> that might have <span class=\"customMeta\" data-dictid=\"6b4030e51a1692777185c6a9dc95b0\">crossed</span> from the <span class=\"customMeta\" data-dictid=\"421fecf0e21692777202704942ac48\">fetus</span> into the <span class=\"customMeta\" data-dictid=\"a191a950d7169277719148e72a75e2\">maternal</span> <span class=\"customMeta\" data-dictid=\"337d16dac5169277718474b97f6e4a\">circulation</span> are<strong> neutralized</strong> before the mother can develop an immune response.</li>\n\t<li>This <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> helps<strong> prevent </strong>the development of <strong>anti-D antibodies</strong>, which could lead to complications in the current or future pregnancies.</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Wait until after the delivery to administer Anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">Immunoglobulin</span> (Option B):</strong> While anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> is also administered after delivery if the baby is Rh-positive, the <span class=\"customMeta\" data-dictid=\"a87d6eeedb16927771967434e19075\">prophylactic</span> dose at 28 weeks is crucial for preventing Rh <span class=\"customMeta\" data-dictid=\"4fe92aaac71692777198234aaa055a\">sensitization</span> during the pregnancy.<strong> </strong></p>\n\n<p><strong>Administer Anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">Immunoglobulin</span> only if there is evidence of <span class=\"customMeta\" data-dictid=\"a191a950d7169277719148e72a75e2\">maternal</span> trauma or <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> (Option C):</strong> <span class=\"customMeta\" data-dictid=\"a87d6eeedb16927771967434e19075\">Prophylactic</span> anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> at 28 weeks is given regardless of whether there is evidence of trauma or bleeding, to ensure comprehensive protection against Rh sensitization. </p>\n\n<p><strong>No further administration of Anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">Immunoglobulin</span> is needed during current pregnancy (Option D):</strong> Even though she received anti-D <span class=\"customMeta\" data-dictid=\"f8fab286571692777189bdfd087071\">immunoglobulin</span> after a previous pregnancy, a <span class=\"customMeta\" data-dictid=\"a87d6eeedb16927771967434e19075\">prophylactic</span> dose at 28 weeks is still necessary in the current pregnancy to prevent sensitization.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/7qzchh4gth0oTop0mjwW1751012811.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/VEENCYn34Wi6MUki979w1751012932.mp3"
    },
    {
      "text": "A 30-year-old woman at 32 weeks gestation presents with ultrasound findings of non-immune hydrops fetalis. What potential underlying cause should be considered?",
      "choices": [
        {
          "id": 0,
          "text": "Maternal Rh incompatibility"
        },
        {
          "id": 1,
          "text": "Gestational diabetes"
        },
        {
          "id": 2,
          "text": "Fetal chromosomal abnormalities"
        },
        {
          "id": 3,
          "text": "Mild maternal hypertension"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C)</strong> <strong>Fetal chromosomal abnormalities</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p><strong>Fetal chromosomal abnormalities</strong>, such as <span class=\"customMeta\" data-dictid=\"5e54fdc4d3169277720003f231621d\">trisomy</span> 21 (Down syndrome) or Turner syndrome (45, XO), are commonly associated with <strong>non-immune <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">hydrops</span> fetalis.</strong> These genetic conditions can disrupt normal <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> development, leading to <strong>cardiovascular abnormalities</strong> and <strong>fluid accumulation.</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Causes of Non-Immune <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">Hydrops</span> Fetalis</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Chromosomal <span class=\"customMeta\" data-dictid=\"e7ed1a964716927771801ab913204a\">abnormality</span> </strong>(20%)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Trisomies (13, 18, 21)</li>\n\t\t\t\t<li>Turner syndrome</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Congenital <span class=\"customMeta\" data-dictid=\"e1fb96fd2416927771830dfed40e14\">cardiac</span> lesions</strong> (15%)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Congenital heart block</li>\n\t\t\t\t<li>Supraventricular tachycardia</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Congenital abnormalities</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Diaphragmatic hernia</li>\n\t\t\t\t<li>Renal abnormality</li>\n\t\t\t\t<li>Cystic hygroma.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Hematological</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Beta-thalassemia</li>\n\t\t\t\t<li>G6PD deficiency</li>\n\t\t\t\t<li>Leukemia</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Infections </strong>(14%)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Parvovirus</li>\n\t\t\t\t<li>Rubella</li>\n\t\t\t\t<li>Toxoplasma</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Placental and Umbilical Cord Pathology</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Twin-to-twin transfusion</li>\n\t\t\t\t<li>Chorioangioma</li>\n\t\t\t\t<li>Umbilical <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">vein</span> thrombosis</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align:center\"><strong>Maternal Diseases </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Uncontrolled diabetes</li>\n\t\t\t\t<li>Severe anemia</li>\n\t\t\t\t<li>Thyrotoxicosis</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Maternal Rh <span class=\"customMeta\" data-dictid=\"722db2c56816927771903e6469e2dc\">incompatibility</span> (Option A) </strong>can lead to<strong> immune <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">hydrops</span> fetalis</strong> (not non-immune hydrops) in which <span class=\"customMeta\" data-dictid=\"a191a950d7169277719148e72a75e2\">maternal</span> antibodies against <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> red blood cells cause <span class=\"customMeta\" data-dictid=\"c2b082746716927771888f0933941d\">hemolysis</span> and subsequent fluid accumulation in the fetus.</p>\n\n<p><strong>Gestational diabetes (Option B) </strong>is not typically associated with non-immune <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">hydrops</span> fetalis. It primarily <strong>affects <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> growth</strong> and can lead to <span class=\"customMeta\" data-dictid=\"aaabbd79f01692777191a03c0b8cbc\">macrosomia</span> (large fetus) and other <span class=\"customMeta\" data-dictid=\"d92cbff33316927771927b4de10a5b\">metabolic</span> issues.</p>\n\n<p><strong>Mild <span class=\"customMeta\" data-dictid=\"a191a950d7169277719148e72a75e2\">maternal</span> hypertension</strong> <strong>(Option D) </strong>alone is unlikely to cause non-immune <span class=\"customMeta\" data-dictid=\"7b09c2b34916927771896ff30fcaa0\">hydrops</span> fetalis. Severe <span class=\"customMeta\" data-dictid=\"a191a950d7169277719148e72a75e2\">maternal</span> <span class=\"customMeta\" data-dictid=\"45372f6c361692777189ff3209e642\">hypertension</span> (pre-eclampsia) with <span class=\"customMeta\" data-dictid=\"797686400a16927771956b27d401ff\">placental</span> <span class=\"customMeta\" data-dictid=\"80feaae4b31692777190ea1ba3fc25\">insufficiency</span> can lead to<strong> fetal</strong> <strong>growth restriction</strong> and sometimes hydrops, but this is less common than other causes like chromosomal abnormalities.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/2NU4BixaHVDQtyUXUZcA1751013016.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/iPcL4K8sNGEbYMj8ZVNF1751013133.mp3"
    }
  ]
}